Nothing Special   »   [go: up one dir, main page]

×
Please click here if you are not redirected within a few seconds.
Apr 11, 2018 · The current study examines DUSPs during the initial phase of Herceptin treatment, in which some changes in gene expression occur, but which is ...
Apr 11, 2018 · This study aims to model the initial effects of Herceptin exposure on DUSPs in HER2-positive breast cancer cells using Boolean modelling.
This study aims to model the initial effects of Herceptin exposure on DUSPs in HER2-positive breast cancer cells using Boolean modelling. Results: We ...
Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis · 9 Citations · 50 References.
Apr 11, 2018 · This study aims to model the initial effects of Herceptin exposure on DUSPs in HER2-positive breast cancer cells using Boolean modelling.
Dive into the research topics of 'Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis ...
Jan 23, 2019 · The present study uses Boolean models combined with experimental data to identify. DUSPs that may be targeted in breast cancer cells for ...
Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis ...
Dive into the research topics of 'Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis ...
People also ask
Jul 26, 2019 · ... Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: A Boolean model analysis. BMC Syst ...